ibudilast has been researched along with Nervous System Diseases in 2 studies
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibudilast (IBD) is a non‑selective (3, 4, 10, 11) phosphodiesterase (PDE) inhibitor, used mainly as a bronchodilator for the treatment of bronchial asthma." | 6.55 | Ibudilast: a non‑selective phosphodiesterase inhibitor in brain disorders. ( Kurkowska-Jastrzębska, I; Mirowska-Guzel, D; Schwenkgrub, J; Zaremba, M, 2017) |
| "Ibudilast (IBD) is a non‑selective (3, 4, 10, 11) phosphodiesterase (PDE) inhibitor, used mainly as a bronchodilator for the treatment of bronchial asthma." | 2.55 | Ibudilast: a non‑selective phosphodiesterase inhibitor in brain disorders. ( Kurkowska-Jastrzębska, I; Mirowska-Guzel, D; Schwenkgrub, J; Zaremba, M, 2017) |
| "Ibudilast is a relatively nonselective phosphodiesterase inhibitor which has been marketed for almost 20 years in Japan for treating asthma." | 2.45 | Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. ( Hutchinson, M; Johnson, K; Rolan, P, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwenkgrub, J | 1 |
| Zaremba, M | 1 |
| Mirowska-Guzel, D | 1 |
| Kurkowska-Jastrzębska, I | 1 |
| Rolan, P | 1 |
| Hutchinson, M | 1 |
| Johnson, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Regeneration in Cervical Degenerative Myelopathy - a Multi-centre, Double-blind, Randomised, Placebo Controlled Trial Assessing the Efficacy of Ibudilast as an Adjuvant Treatment to Decompressive Surgery for Degenerative Cervical Myelopathy[NCT04631471] | Phase 3 | 400 participants (Anticipated) | Interventional | 2021-12-22 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ibudilast and Nervous System Diseases
| Article | Year |
|---|---|
Ibudilast: a non‑selective phosphodiesterase inhibitor in brain disorders.
Topics: Animals; Brain Diseases; Brain Edema; Brain Infarction; Humans; Nervous System Diseases; Neurons; Ph | 2017 |
Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease.
Topics: Bronchodilator Agents; Humans; Nervous System Diseases; Pyridines; Respiratory Tract Diseases | 2009 |